Safety and Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails

NCT01208129 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

458

Enrollment

INDUSTRY

Sponsor class

Conditions

Onychomycosis

Interventions

DRUG: NAB001
DRUG: Placebo control

Sponsor

Promius Pharma, LLC